Theralink® Technologies Appoints Dr. Mattia Cremona as its Director of its Biopharma Laboratory

Seasoned Cancer Research Fellow with specialized interest in Reverse Phase Protein Array Technology to bolster Theralink’s management team GOLDEN, Colo., Nov. 7, 2022 /PRNewswire/ — Theralink Technologies, Inc. (OTC: THER) (“Theralink” or the “Company”), a precision oncology company with…

Click here to view original post